Oral Session 3-10A MM: Clinical trials

[OS3-10A-4] Randomized phase II study to optimize MPB in untreated transplant-ineligible myeloma: JCOG1105

Shinsuke Iida¹, Dai Maruyama², Gakuto Ogawa³, Shigeru Kusumoto¹, Suguru Fukuhara², Noriko Fukuhara⁴, Sachiko Seo⁵, Kana Miyazaki⁶, Makoto Yoshimitsu⁷, Junya Kuroda⁸, Norifumi Tsukamoto⁹, Hideki Tsujimura¹⁰, Akira Hangaishi¹¹, Takahiro Yamauchi¹², Takahiko Utsumi¹³, Ishikazu Mizuno¹⁴, Yasushi Takamatsu¹⁵, Yasuyuki Nagata¹⁶, Koichiro Minauchi¹⁷, Eiichi Ohtsuka¹⁸, Ichiro Hanamura¹⁹, Takashi Tokunaga²⁰, Shinichiro Yoshida²¹, Satoshi Yamazaki²², Youko Suehiro²³, Yutaro Kamiyama²⁴, Kenichi Miyamoto³, Yuko Watanabe³, Kunihiro Tsukasaki⁵, Hirokazu Nagai²⁰ (1.Hematol. & Oncol., Nagoya City Univ., Nagoya, Japan, 2.Hematol., National Cancer Center Hosp., Tokyo, Japan, 3.JCOG Data Center, National Cancer Center Hosp., Tokyo, Japan, 4.Hematol., & Rheumatol., Tohoku Univ. Hosp., Sendai, Japan, 5.Hematol., National Cancer Center Hosp. East, Kashiwa, Japan, 6.Hematol., & Oncol., Mie Univ., Tsu, Japan, 7.Hematol. & Immunol., Kagoshima Univ. Hosp., Kagoshima, Japan, 8.Div. Hematol. & Oncol., Kyoto Pref. Univ., Kyoto, Japan, 9.Hematol., Gunma Univ., Maebashi, Japan, 10.Hematol.-Oncol., Chiba Cancer Center, Chiba, Japan, 11.Hematol., NTT Med. Center Tokyo, Tokyo, Japan, 12.Hematol. & Oncol., Univ. of Fukui, Fukui, Japan, 13.Hematol. & Oncol., Shiga General Hosp., Moriyama, Japan, 14.Hematol., Hyogo Cancer Center, Akashi, Japan, 15.Med. Oncol., Hematol. & Infectious Dis., Fukuoka Univ., Fukuoka, Japan, 16.Int. Med. III, Hamamatsu Univ. Sch. of Med., Hamamatsu, Japan, 17.Hematol., Sapporo Hokuyu Hosp., Sapporo, Japan, 18.Hematol., Oita Pref. Hosp., Oita, Japan, 19.Hematol., Aichi Med. Univ., Nagakute, Japan, 20.Hematol., NHO Nagoya Med. Center, Nagoya, Japan, 21.Hematol., NHO Nagasaki Med. Center, Ohmura, Japan, 22.Hematol. & Clin. Res. Inst., NHO Kyushu Med. Center, Fukuoka, Japan, 23.Hematol., NHO Kyushu Cancer Center, Fukuoka, Japan, 24.Clin. Oncol. & Hematol., The Jikei Univ., Tokyo, Japan)